How many insider trades does FilingIQ track for VANI?

FilingIQ tracks 154 Form 4 insider transactions for VANI (Vivani Medical, Inc.), covering filings from Aug 30, 2022 onwards. 5 of those were filed in the last 90 days.

Are VANI insiders net buyers or net sellers?

Across the full Form 4 history for VANI, 141 transactions (92%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.

Where does VANI insider data come from?

Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.

What sector is VANI in?

Vivani Medical, Inc. (VANI) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $101.63M.

VANI insider trading

Healthcare

Vivani Medical, Inc. — scored insider trade history from SEC Form 4 filings, parsed and contextualised by FilingIQ.

Total Form 4 trades

154

Last 90 days

Buys / sells

92% / 0%

Market cap

$101.63M

About Vivani Medical, Inc.

Vivani Medical, Inc., a clinical-stage biopharmaceutical company, engages in the development of miniaturized and subdermal drug implants that treat chronic diseases. The company uses its NanoPortal implant technology to develop and potentially commercialize drug implant candidates in the treatment of chronic disease and medication non-adherence. Its pipeline includes NPM-115, a high-dose exenatide implant candidate is in clinical stage development for the treatment of chronic weight management in patients with obesity or overweight; NPM-119, an exenatide implant candidate is in preclinical stage development for the treatment of patients with type 2 diabetes; NPM-139, a miniature and subdermal GLP-1 implant in development for chronic weight management; and OKV-119, an exenatide implant for metabolic diseases in cats. The company is headquartered in Alameda, California.

Company website: www.vivani.com

VANI insider activity at a glance

FilingIQ has scored 154 insider transactions for VANI since Aug 30, 2022. The most recent filing in our index is dated Apr 15, 2026.

Across the full history, 141 open-market purchases and 0 open-market sales were filed under transaction codes P and S respectively. Compensatory share awards (code A) and option exercises (code M) are tracked separately and not counted here.

The average FilingIQ composite score on VANI insider trades is 54.3/100, produced by FilingIQ's multi-factor Form 4 model. Model framework documented at methodology.

View live VANI trades on FilingIQ Raw filings on SEC EDGAR

Latest VANI Form 4 filings

Most recent disclosures. Sign up to filter by score, transaction code, or insider role.

Other Healthcare tickers with recent insider activity

UTHR 1,098

UNITED THERAPEUTICS Corp

APLS 279

Apellis Pharmaceuticals, Inc.

KMDA 218

KAMADA LTD

BMY 185

BRISTOL MYERS SQUIBB CO

ADPT 184

Adaptive Biotechnologies Corp

GH 169

Guardant Health, Inc.

ISRG 166

INTUITIVE SURGICAL INC

VTRS 165

Viatris Inc

Frequently asked

How many insider trades does FilingIQ track for VANI?: FilingIQ tracks 154 Form 4 insider transactions for VANI (Vivani Medical, Inc.), covering filings from Aug 30, 2022 onwards. 5 of those were filed in the last 90 days.
Are VANI insiders net buyers or net sellers?: Across the full Form 4 history for VANI, 141 transactions (92%) were open-market purchases and 0 (0%) were open-market sales. Compensatory awards and option exercises are filtered out of these counts.
Where does VANI insider data come from?: Every transaction shown on this page is sourced directly from SEC EDGAR Form 4 filings. FilingIQ parses the raw XML, normalises insider identity across reporting variations, and scores each trade on its multi-factor composite model.
What sector is VANI in?: Vivani Medical, Inc. (VANI) is classified in the Healthcare sector, specifically Biotechnology, with a current market capitalisation of $101.63M.

Methodology & sources

Every VANI insider transaction shown on FilingIQ is parsed directly from a public SEC Form 4 XML filing. Insider identity is normalised across reporting variants (CIK changes, name spellings, related-party indirect holdings). The FilingIQ composite score is documented in full on the team page and algo disclosure. Not investment advice; see disclaimer.